ScoreWhy is Jenburkt Pharmaceuticals Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 8.47% and Operating profit at 14.38% over the last 5 years
- PAT(Q) At Rs 5.93 cr has Fallen at -28.1% (vs previous 4Q average)
- CASH AND CASH EQUIVALENTS(HY) Lowest at Rs 9.65 cr
- DEBTORS TURNOVER RATIO(HY) Lowest at 6.99 times
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Jenburkt Pharma for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Jenburkt Pharma
0.93%
0.02
37.65%
Sensex
-2.38%
-0.19
12.70%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
8.47%
EBIT Growth (5y)
14.38%
EBIT to Interest (avg)
30.72
Debt to EBITDA (avg)
0.11
Net Debt to Equity (avg)
-0.04
Sales to Capital Employed (avg)
1.00
Tax Ratio
27.39%
Dividend Payout Ratio
25.99%
Pledged Shares
0
Institutional Holding
0.12%
ROCE (avg)
35.97%
ROE (avg)
18.99%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
14
Industry P/E
31
Price to Book Value
2.43
EV to EBIT
11.72
EV to EBITDA
10.82
EV to Capital Employed
2.50
EV to Sales
2.64
PEG Ratio
4.26
Dividend Yield
NA
ROCE (Latest)
22.13%
ROE (Latest)
17.73%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend0What is working for the Company
NO KEY POSITIVE TRIGGERS
-12What is not working for the Company
PAT(Q)
At Rs 5.93 cr has Fallen at -28.1% (vs previous 4Q average
CASH AND CASH EQUIVALENTS(HY)
Lowest at Rs 9.65 cr
DEBTORS TURNOVER RATIO(HY)
Lowest at 6.99 times
PBDIT(Q)
Lowest at Rs 7.42 cr.
OPERATING PROFIT TO NET SALES (Q)
Lowest at 17.25%
PBT LESS OI(Q)
Lowest at Rs 6.48 cr.
EPS(Q)
Lowest at Rs 13.45
Loading Valuation Snapshot...
Here's what is not working for Jenburkt Pharma
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 6.48 cr has Fallen at -32.3% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 9.57 CrMOJO Watch
Near term PBT trend is very negative
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 5.93 cr has Fallen at -28.1% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 8.25 CrMOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Lowest at Rs 7.42 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Lowest at 17.25%
in the last five quartersMOJO Watch
Company's efficiency has deteriorated
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs 6.48 cr.
in the last five quartersMOJO Watch
Near term PBT trend is negative
PBT less Other Income (Rs Cr)
Earnings per Share (EPS) - Quarterly
Lowest at Rs 13.45
in the last five quartersMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (Rs)
Cash and Cash Equivalents - Half Yearly
Lowest at Rs 9.65 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debtors Turnover Ratio- Half Yearly
Lowest at 6.99 times
in the last five half yearly periodsMOJO Watch
Company's pace of settling its Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
